RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE

RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE

Show other versions (1)

The clinical, cell and genetic factors are distinguished among reasons for resistance to antiplatelet drugs. There are many methods to detect sensitivity to antiplatelet drugs, but they all have disadvantages. Moreover, there is no unified approach for interpretation of received results, and no reco...

Full description

Bibliographic Details
Main Authors:	D. H. Aynetdinova, A. E. Udovichenko, V. A. Sulimov
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-12-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	antiplatelet drugs clopidogrel resistance to acetylsalicylic acid
Online Access:	https://www.rpcardio.online/jour/article/view/458

Similar Items

ANTIPLATELET DRUGS RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND OBLITERATIVE ATHEROSCLEROSIS OF LOWER LIMB ARTERIES ASSOCIATED WITH DIABETES MELLITUS TYPE 2
by: E. V. Gorjacheva, et al.
Published: (2016-01-01)

High residual platelet reactivity during dual antiplatelet therapy, found by optical aggregometry and the rate of atherothrombotic complications after coronary artery stenting in patients with ischemic heart disease in clinical practice
by: N. F. Puchinyan, et al.
Published: (2016-09-01)

ANTIPLATELET THERAPY RESISTANCE IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION
by: D. H. Ainetdinova, et al.
Published: (2016-01-01)

Patient-specific choice of an antiplatelet drug for long-term therapy of coronary heart disease: rationale and implementationL
by: NA Mazur
Published: (2014-12-01)

Short-Term Clinical Outcomes of Single Versus Dual Antiplatelet Therapy after Infrainguinal Endovascular Treatment for Peripheral Arterial Disease
by: Jetty Ipema, et al.
Published: (2020-10-01)

INDIVIDUAL ANTIPLATELET THERAPY IN PATIENTS WITH ATHEROSCLEROSIS OF LOWER EXTREMITIES: MYTH OR REALITY?
by: O. V. Sirotkina, et al.
Published: (2018-01-01)

EFFECTIVE USE OF ANTIPLATELETS AFTER RECONSTRUCTIVE OPERATIONS
by: D. V. Krylov, et al.
Published: (2017-11-01)

Effects of Antiplatelet Drugs on Platelet-Dependent Coagulation Reactions
by: Ivan A. Muravlev, et al.
Published: (2023-07-01)

EFFECTS OF ACETYLSALICYLIC ACID AND CLOPIDOGREL ON MORPHOFUNCTIONAL STATUS OF ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: A. L. Alyavi, et al.
Published: (2016-01-01)

Antiplatelet resistance and thromboembolic complications in neurointerventional procedures
by: Thomas J Oxley, et al.
Published: (2011-12-01)

Efficacy and safety of antiplatelet drugs in patients with chronic kidney disease
by: İbrahim Yıldız, et al.
Published: (2014-07-01)

Role of clopidogrel role in secondary prevention of ischemic stroke
by: K. S. Meshkova, et al.
Published: (2014-12-01)

Fifteen-Year Nationwide Trend in Antiplatelet Treatment among Drug-Eluting Stent Recipients in Korea: Many Patients Receive Very Prolonged Dual-Antiplatelet Treatment, and Newer Drugs Are Replacing the Older Ones
by: Sunwon Kim, et al.
Published: (2023-04-01)

RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: D. H. Aynetdinova, et al.
Published: (2015-12-01)

UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE
by: S. Yu. Martsevich, et al.
Published: (2015-12-01)

ON THE 125TH ANNIVERSARY OF ACETYLSALICYLIC ACID
by: I. N. Bokarev, et al.
Published: (2016-01-01)

Molecular and metabolic characteristics of changes in the platelet sensitivity to antiplatelet therapy in patients with coronary artery disease before and after coronary artery bypass grafting
by: M. D. Goncharov, et al.
Published: (2021-07-01)

THE ROLE OF MODERN ANTIPLATELET THERAPY IN PREVENTION OF ATHEROTHROMBOSIS: THE IMPORTANCE OF CLOPIDOGREL AND ITS GENERIC DRUGS
by: O. V. Gaisenok
Published: (2016-01-01)

POSSIBILITIES OF CLINICAL LABORATORY EVALUATION OF ANTIPLATELET THERAPY EFFECTIVENESS IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: O. V. Sirotkina, et al.
Published: (2015-09-01)

Oral Antiplatelet Therapy for Secondary Prevention of Non-Cardioembolic Ischemic Cerebrovascular Events
by: Leonardo De Luca, et al.
Published: (2021-04-01)

Use of 3D Printing for the Development of Biodegradable Antiplatelet Materials for Cardiovascular Applications
by: Juan Domínguez-Robles, et al.
Published: (2021-09-01)

Best duration of dual antiplatelet therapy after drug-eluting stent implantation: an updated network meta-analysis of randomized controlled trials
by: Mahmoud Barbarawi, et al.
Published: (2019-01-01)

Antiplatelet treatment patterns and outcomes of secondary stroke prevention in the United States
by: Ellen O'Brien, et al.
Published: (2023-02-01)

ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE
by: S. Yu. Martsevich, et al.
Published: (2014-07-01)

ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE
by: S. Yu. Martsevich, et al.
Published: (2014-07-01)

Early discontinuation of dual antiplatelet therapy via acetylsalicylic acid cessation in patients with acute coronary syndrome undergoing percutaneous coronary interventions to reduce the bleeding risk
by: O. V. Averkov
Published: (2021-02-01)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015-12-01)

Antiplatelet Therapy Aims and Strategies in Asian Patients with Acute Coronary Syndrome or Stable Coronary Artery Disease
by: Chor-Cheung Tam, et al.
Published: (2022-12-01)

Antiplatelet drugs and liver fibrosis
by: Pamela Czajka, et al.
Published: (2022-02-01)

MONITORING OF THE EFFECTIVENESS OF ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE
by: N. F. Puchinian, et al.
Published: (2017-03-01)

Aspirin resistance: causes, clinical significance, correction
by: G.F. Gendeleka, et al.
Published: (2022-04-01)

ANTITHROMBIC THERAPY IN THE PRIMARY PREVENTION OF STROKE
by: I. S. Yavelov
Published: (2009-03-01)

Antiplatelet therapy in secondary prevention of ischemic stroke
by: V. A. Parfyonov, et al.
Published: (2015-12-01)

Antitumor effects of cardiovascular drugs
by: I. I. Shaposhnik, et al.
Published: (2020-10-01)

Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases
by: Jan Kiebist, et al.
Published: (2021-09-01)

Effects of thienopyridine class antiplatelets on bleeding outcomes following robot-assisted radical prostatectomy
by: Masashi Kubota, et al.
Published: (2024-03-01)

Dual antiplatelet therapy is associated with high α-tubulin acetylation in circulating platelets from coronary artery disease patients
by: Valentine Robaux, et al.
Published: (2023-12-01)

DENTAL MANAGEMENT AND BLEEDING COMPLICATIONS OF PATIENTS ON LONG-TERM ORAL ANTIPLATELET THERAPY. REVIEW OF EXISTING STUDIES AND GUIDELINES.
by: Atanaska Dinkova, et al.
Published: (2013-06-01)

Comparison of the Degree of Gastric Mucosal Injury between Patients Who Are Receiving Dual Antiplatelet Therapy or Single Antiplatelet Therapy
by: Yuji Shimada, et al.
Published: (2022-09-01)

Dual antiplatelet therapy for reduction in mortality in patients with acute and chronic coronary syndromes
by: Maciej Lesiak, et al.
Published: (2021-12-01)